Stories by Matthew Perrone

Wednesday, April 27, 2016

Lawmakers accuse Valeant of price gouging on some drugs

Senate lawmakers accused embattled drugmaker Valeant Pharmaceuticals of hiking prices to reward Wall Street investors at the expense of patients.
By Matthew Perrone

Tuesday, March 22, 2016

FDA will add strongest warning labels to most widely used painkillers

WASHINGTON - Fede­ral health regulators will add their strongest warning labels to the most widely prescribed painkillers, part of a multi-pronged government campaign to stem an epidemic of abuse ...
By Matthew Perrone

Tuesday, March 15, 2016

CDC advice aims to cut prescribing painkillers

WASHINGTON - Prescription painkillers should not be a first choice for treating common ailments such as back pain and arthritis, according to new federal guidelines designed to reshape how doctors ...
By Matthew Perrone

Friday, Feb. 19, 2016

Hospital visit fees can be a surprise

WASHINGTON - Recovering from a medical procedure is always a challenge, but getting hit with unexpected insurance fees can add financial hardship to the process.
By Matthew Perrone

Wednesday, Jan. 20, 2016

Reviled drug executive gets subpoena by House panel

WASHINGTON — House lawmakers have issued a subpoena to compel former Turing Pharma­ceuticals CEO Martin Shkreli, reviled for price-gouging, to appear at a congressional hearing Tuesday.
By Matthew Perrone

Friday, Dec. 18, 2015

FDA proposes ban on indoor tanning for minors

WASHINGTON — Anyone under the age of 18 would be barred from using indoor tanning equipment, under a federal proposal to help reduce skin cancer linked to the devices.
By Matthew Perrone

Wednesday, Nov. 4, 2015

Senate committee seeks information on drug price hikes

A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical ...
By Matthew Perrone

Wednesday, Aug 19, 2015

FDA approves first pill aimed at boosting female libido

The Food and Drug Administration has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the ...
By Matthew Perrone

Friday, April 3, 2015

On The Money: Finding your way with a patient navigator

Patient navigators can help cut through health care's red tape and potentially save money.
By Matthew Perrone

Tuesday, Feb. 17, 2015

After lobbying push, drugmaker resubmits women's sex pill

Drugmaker enlists support from lawmakers, women's groups to boost bid for female sex pill.
By Matthew Perrone

Thursday, Nov. 20, 2014

Soaring generic drug prices draw Senate scrutiny

WASHINGTON - Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, ...
By Matthew Perrone

Friday, Oct. 10, 2014

New once-a-day pill for hepatitis C wins FDA approval

WASHINGTON - Federal health officials have approved a daily pill that can cure the most common form of hepatitis C. But the drug's $1,125-per-pill price is sure to increase criticism of drugmaker ...
By Matthew Perrone

Thursday, Sept. 11, 2014

Silicon Valley struggles with regulations

WASHINGTON — From Apple’s new smartwatch that tracks heartbeats to contact lenses that measure blood sugar – Silicon Valley is pouring billions into gadgets and apps designed to transform health ...
By Matthew Perrone

Sunday, July 13, 2014

Who pays your doc? Coming soon to a site near you

Nearly 95 percent of U.S. physicians accept gifts, meals, payments, travel and other services from companies that make the drugs and medical products they prescribe, according to the "New England ...
By Matthew Perrone

Tuesday, Jan. 7, 2014

Feds crack down on weight loss aids

WASHINGTON - Makers of a weight loss additive called Sensa will return more than $26 million to consumers to settle federal charges that the company used deceptive advertising.
By Matthew Perrone

Thursday, Aug 29, 2013

J&J launches new cap to curb Tylenol overdoses

WASHINGTON - Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever.
By Matthew Perrone

Tuesday, July 23, 2013

FDA cracks down on illegal diabetes remedies

WASHINGTON - The Food and Drug Admini­stra­tion is cracking down on more than a dozen companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription ...
By Matthew Perrone

Wednesday, March 20, 2013

Martinez compounding pharmacy recalls eye drug

The FDA said Wednesday that Clinical Specialties of Martinez has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder ...
By Matthew Perrone

Saturday, March 31, 2012

Tobacco companies must report chemicals

WASHINGTON - Tobacco companies will be required to report the levels of dangerous chemicals found in their products under the latest rules for the tobacco industry.
By Matthew Perrone
Search Augusta jobs